General Cannabis Corporation offers various products and services to companies in the cannabis industry. The Company's integrated solution ranges from operational and compliance consulting to security and marketing to financing needs. The Company's segments include Security and Cash Management Services; Marketing and Products; Consulting and Advisory, and Finance and Real Estate. The Security and Cash Management Services segment includes the operations of Iron Protection Group, LLC. The Marketing and Products segment includes the operations of Chiefton Supply Co. (Chiefton), an apparel and design company. The Consulting and Advisory segment offers consulting services, such as obtaining licenses, compliance, cultivation and logistical support, to the cannabis industry through Next Big Crop. The Finance and Real Estate segment includes real estate leasing; Shared Office Space, Networking and Event Services, and Industry Finance and Equipment Leasing Services.
Industry, Sector and Symbol:
- Sector: N/A
- Industry: N/A
- Sub-Industry: N/A
- Symbol: NASDAQ:CANN
- CUSIP: N/A
- Web: N/A
- 50 Day Moving Avg: $1.99
- 200 Day Moving Avg: $2.54
- 52 Week Range: $0.50 - $5.19
Sales & Book Value:
- Trailing P/E Ratio: N/A
- P/E Growth: 0.00
- Annual Revenue: $3.01 million
- Price / Sales: N/A
- Book Value: ($0.62) per share
- Price / Book: -2.77
- Average Volume: 120,691 shs.
Frequently Asked Questions for General Cannabis Corp (NASDAQ:CANN)
What is General Cannabis Corp's stock symbol?
General Cannabis Corp trades on the NASDAQ under the ticker symbol "CANN."
How were General Cannabis Corp's earnings last quarter?
General Cannabis Corp (NASDAQ:CANN) released its earnings results on Monday, November, 7th. The company reported ($0.93) earnings per share for the quarter. The firm had revenue of $0.81 million for the quarter. View General Cannabis Corp's Earnings History.
Who are some of General Cannabis Corp's key competitors?
Some companies that are related to General Cannabis Corp include Rocky Mountain Chocolate Factory (RMCF), Nano Dimension Ltd - (NNDM), Sharps Compliance Corp. (SMED), Imprimis Pharmaceuticals (IMMY), Egalet Corp (EGLT), Sunesis Pharmaceuticals (SNSS), Evolving Systems (EVOL), Concordia International Corp (CXRX), Dicerna Pharmaceuticals (DRNA), Dixie Group (DXYN), Medallion Financial Corp (MFIN), Second Sight Medical Products (EYES), Innocoll Holdings PLC (INNL), Commercewest Bank Com (CWBK), Sierra Oncology (SRRA), Patriot National Bancorp (PNBK), Stein Mart (SMRT) and Peak Resorts (SKIS).
Who are General Cannabis Corp's key executives?
General Cannabis Corp's management team includes the folowing people:
- Michael R. Feinsod, Chairman of the Board, Independent Director
How do I buy General Cannabis Corp stock?
Shares of General Cannabis Corp can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is General Cannabis Corp's stock price today?
MarketBeat Community Rating for General Cannabis Corp (NASDAQ CANN)MarketBeat's community ratings are surveys of what our community members think about General Cannabis Corp and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
One share of General Cannabis Corp stock can currently be purchased for approximately $1.72.
Consensus Ratings for General Cannabis Corp (NASDAQ:CANN) (?) The ratings breakdown includes the most recent rating from each analyst that has rated the stock within the last twelve months. The ratings score is a calculation of the average number of sell, hold, buy and strong buy ratings (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). The consensus price target is a mean average of the most recent price target set by each analyst that has set a price target for the stock in the last twelve months.
|Ratings Breakdown: ||No ratings tracked in the last 12 months.|
|Consensus Rating:||N/A (Score: NaN)|
|Consensus Price Target: ||N/A|
Analysts' Ratings History for General Cannabis Corp (NASDAQ:CANN)
No equities research coverage for this company has been tracked by MarketBeat.com
Earnings History for General Cannabis Corp (NASDAQ:CANN)Earnings History by Quarter for General Cannabis Corp (NASDAQ CANN)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|11/7/2016||Q3 2016||($0.93)||$0.81 million||View||N/A|
Earnings Estimates for General Cannabis Corp (NASDAQ:CANN)
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for General Cannabis Corp (NASDAQ:CANN)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for General Cannabis Corp (NASDAQ:CANN)Insider Trades by Quarter for General Cannabis Corp (NASDAQ:CANN)
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|2/7/2017||Michael Feinsod||Director||Sell||200,000||$1.25||$250,000.00|| |
|1/30/2017||Michael R Kelsey||Major Shareholder||Sell||1,290,090||$2.75||$3,547,747.50|| |
|1/25/2017||Shelly Whitson||Insider||Sell||20,000||$2.51||$50,200.00|| |
|10/17/2016||Robert Lawrence Frichtel||CEO||Sell||75,000||$3.59||$269,250.00|| |
|10/12/2016||Robert Lawrence Frichtel||CEO||Sell||25,000||$3.71||$92,750.00|| |
|2/11/2016||Michael Feinsod||Director||Buy||3,000||$0.41||$1,230.00|| |
|2/11/2016||Robert Lawrence Frichtel||CEO||Buy||4,000||$0.39||$1,560.00|| |
|1/20/2016||Robert Lawrence Frichtel||CEO||Buy||2,000||$0.48||$960.00|| |
|12/15/2015||Michael Feinsod||Director||Buy||12,700||$0.45||$5,715.00|| |
Headline Trends for General Cannabis Corp (NASDAQ:CANN)
Latest Headlines for General Cannabis Corp (NASDAQ:CANN)
General Cannabis Corp (CANN) Chart for Monday, May, 29, 2017